Treatment Options for Pediatric Leukemia
Location
Turner Gymnasium
Access Type
Campus Access Only
Presentation Type
Printed poster
Entry Number
2340
Start Date
4-16-2025 12:00 PM
End Date
4-16-2025 1:15 PM
School
School of Medicine and Health Sciences
Department
Nursing
Abstract
Treatment Options for Pediatric Leukemia
Leukemia is the most prominent cancer affecting children and teens with treatment options still being researched. Stem cell therapy has emerged as a potential treatment option in addition to chemotherapy. This literature analysis explores two specific treatments for pediatric patients diagnosed with leukemia to examine how it impacts the improvement of patient outcomes. By reviewing existing research from 2019 to 2024, the analysis reveals that the combination of stem cell therapy with chemotherapy leverages the effects of both treatments. The combined approach of stem cell therapy and chemotherapy has been proven to improve remission rates and the overall survival of patients compared to chemotherapy alone. With this treatment, the chemotherapy destroys both healthy and cancer cells, while the stem cells restore the damaged cells. By incorporating stem cell therapy with chemotherapy, the number of healthy cells is increased, which enables higher doses of chemotherapy to be administered. This approach results in improved outcomes and reduces the adverse effects associated with the insufficiency of healthy cells. Despite the possible complications, these findings underscore the importance of integrating both therapies to strengthen treatment outcomes, while minimizing adverse effects and striving for safer interventions in the treatment of pediatric leukemia.
Keywords: pediatric leukemia, chemotherapy, stem cell therapy, literature analysis, cancer
Primary Faculty Mentor(s)
Dr. Susan Braud
Primary Faculty Mentor(s) Department
Nursing
Rights Statement
The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.
Treatment Options for Pediatric Leukemia
Turner Gymnasium
Treatment Options for Pediatric Leukemia
Leukemia is the most prominent cancer affecting children and teens with treatment options still being researched. Stem cell therapy has emerged as a potential treatment option in addition to chemotherapy. This literature analysis explores two specific treatments for pediatric patients diagnosed with leukemia to examine how it impacts the improvement of patient outcomes. By reviewing existing research from 2019 to 2024, the analysis reveals that the combination of stem cell therapy with chemotherapy leverages the effects of both treatments. The combined approach of stem cell therapy and chemotherapy has been proven to improve remission rates and the overall survival of patients compared to chemotherapy alone. With this treatment, the chemotherapy destroys both healthy and cancer cells, while the stem cells restore the damaged cells. By incorporating stem cell therapy with chemotherapy, the number of healthy cells is increased, which enables higher doses of chemotherapy to be administered. This approach results in improved outcomes and reduces the adverse effects associated with the insufficiency of healthy cells. Despite the possible complications, these findings underscore the importance of integrating both therapies to strengthen treatment outcomes, while minimizing adverse effects and striving for safer interventions in the treatment of pediatric leukemia.
Keywords: pediatric leukemia, chemotherapy, stem cell therapy, literature analysis, cancer